“Dual diagnosis” and “co-occurring disorder” almost always describe the same clinical situation: a mental disorder and a substance use disorder happening in the same person at the same time. Both fall under the broader medical concept of comorbidity, which covers any two or more conditions occurring together. The wording still matters, because how a program defines these terms often predicts how closely it screens for and treats both conditions at once.
TL;DR:
- Ask programs to define dual diagnosis, confirm that intake screens for both conditions, and explain how screening results change the treatment plan.
- A positive screening result is not a diagnosis; clinicians should conduct a full assessment and compare symptom timelines with substance use and withdrawal.
- SAMHSA estimates that 21.5 million U.S. adults had a substance use disorder and mental illness in one recent year, highlighting the scale.
- Choose programs that treat both conditions concurrently through a coordinated team, with psychiatric medication oversight and reassessment as symptoms change during recovery.
Table of Contents
- What dual diagnosis and co-occurring disorder actually mean
- How comorbidity ties the two terms together
- Why labels vary across programs and what to ask
- What the terminology means for your treatment plan
- Screening and assessment: separating substance effects from standalone disorders
- Common co-occurring pairings and what they involve
- Where these terms came from
- Do diagnostic systems treat these terms differently?
- Why treating both conditions at once is hard
- Stigma still shapes how people seek help
- Evidence-based approaches for treating both conditions together
- Why a coordinated care team matters
- Questions worth asking before you commit to a program
- Getting integrated care that treats both conditions as one picture
- FAQ
- Sources
What dual diagnosis and co-occurring disorder actually mean
MedlinePlus describes dual diagnosis and co-occurring disorders as referring to the same thing in most clinical conversations: a person living with both a mental disorder and a substance use disorder simultaneously. MedlinePlus classifies dual diagnosis as a type of comorbidity, not a separate category of illness. The term doesn’t point to one specific combination of conditions; it simply flags that two things are present at once.
In behavioral health settings, SAMHSA uses “co-occurring disorders” as its working phrase, defining it as at least one mental disorder paired with at least one substance use disorder. SAMHSA uses the term “co-occurring disorders” in its guidance, while terminology can vary across settings and sources.
A few common pairings illustrate how broad the category is:
- Depression combined with alcohol use disorder, where low mood and drinking often reinforce each other.
- Post-traumatic stress disorder alongside opioid use disorder, where substances are sometimes used to manage trauma symptoms.
- ADHD paired with stimulant misuse, where impulsivity and self-medication can overlap.
How comorbidity ties the two terms together
Comorbidity is the umbrella. A 2024 peer-reviewed narrative review describes co-occurring substance use and psychiatric conditions using several interchangeable labels: comorbid conditions, concurrent disorders, and dual diagnoses. The review notes that this overlap creates real diagnostic and treatment complexity, since symptoms from one condition can mask or mimic symptoms of the other.
In addiction treatment specifically, “co-occurring” tends to mean one precise thing: a substance use disorder plus a mental health disorder. Comorbidity is wider. It can describe two physical illnesses, two mental health conditions with no substance involved, or any mix of chronic conditions a person is managing at once. A few distinctions worth holding onto:
- Comorbidity is the general medical term for any two or more conditions occurring together, not just mental health and substance use.
- Co-occurring disorder is a comorbidity subtype specific to addiction treatment settings.
- Older sources sometimes use “dual diagnosis” more loosely, so it’s worth asking a clinician exactly which two conditions they’re referring to.
Why labels vary across programs and what to ask
Terminology in this field is not fully standardized. SAMHSA’s treatment improvement protocol material acknowledges that the field uses many overlapping terms, some of which are outdated or applied inconsistently, which is why the guidance leans toward clarifying definitions directly with clients rather than assuming everyone means the same thing by “dual diagnosis.” Person-first language has also shifted over time, moving away from labels that reduce someone to their diagnosis and toward phrasing that names the conditions without defining the person by them.
An estimated 21.5 million adults in the United States had both a substance use disorder and a mental illness in a single recent year, according to SAMHSA’s co-occurring disorders treatment guidance. That scale explains why consistent terminology and screening practices carry real weight in treatment planning.
A short list of questions can cut through the ambiguity when you’re evaluating a program:
- Ask which two specific conditions the program means when it says “dual diagnosis.”
- Ask whether intake includes screening for both substance use and mental health, not just one.
- Ask how the answers to those screenings change the treatment plan.
What the terminology means for your treatment plan
Whichever term a program uses, the clinical standard they should be following is the same: integrated care, meaning both conditions are treated at the same time by the same coordinated team rather than one after the other. A comprehensive narrative review found that integrated care models combining substance use and mental health treatment show better outcomes than treating the conditions separately, and the review points to holistic, multi-domain care as the reason why. SAMHSA’s guidance backs this up, recommending concurrent treatment delivered by providers trained in both areas, phased approaches, and closely monitored medication management.
Integrated care typically includes:
- Individual and group psychotherapy addressing both the mental health condition and the substance use pattern.
- Medication management with psychiatric oversight, adjusted as recovery progresses.
- Peer support and case management to handle practical barriers like housing or employment.
Our Dual Diagnosis Support program provides support for co-occurring mental health and substance use disorders.
Pro Tip: Ask any program directly about team composition, specifically whether a psychiatrist or psychiatric nurse practitioner is involved in ongoing medication monitoring, not just an initial evaluation.
Screening and assessment: separating substance effects from standalone disorders
Screening and assessment are two different steps. Screening is a quick process that flags whether someone might need a closer look; assessment is the longer, more detailed process that defines exactly what’s going on and what treatment should follow, as described in SAMHSA’s screening and assessment guidance. A positive screen should always lead to a full assessment rather than a diagnosis on the spot.
One of the harder parts of that assessment is figuring out whether symptoms are substance-induced (caused by intoxication or withdrawal) or whether they reflect an independent mental health disorder that exists regardless of substance use. Clinicians often rely on detailed history-taking, timeline follow-back interviews, and structured diagnostic tools to make that distinction, since accurate separation affects medication choices and the overall treatment sequence.
During intake, you can generally expect:
- A screening questionnaire covering both substance use patterns and mental health symptoms.
- A full clinical interview that builds a timeline of when symptoms and substance use started relative to each other.
- A period of observation or stabilization, since some symptoms clear up once substances are out of the body.
- A reassessment once withdrawal has passed, to confirm which symptoms are truly independent.
Common co-occurring pairings and what they involve
Examples of co-occurring conditions can include combinations such as those described below. Depressive disorders and alcohol use disorder can co-occur. Clinicians need to assess whether symptoms are substance-related or reflect an independent disorder when planning treatment.
PTSD and a substance use disorder can co-occur. Integrated assessment can help clinicians plan care that addresses both conditions without assuming one caused the other.
ADHD or bipolar disorder alongside stimulant or alcohol misuse raises its own considerations:
- ADHD or bipolar disorder alongside substance use can call for careful assessment of both conditions when planning treatment.
- When ADHD and stimulant use disorder co-occur, clinicians should consider both conditions when planning treatment.
- Treatment planning for bipolar disorder alongside substance use should consider both conditions rather than assuming one must be treated first.
Where these terms came from
“Dual diagnosis” can be used inconsistently, including to refer broadly to more than one diagnosis. In mental health and substance-use contexts, “dual diagnosis” commonly refers to a mental disorder occurring alongside a substance use disorder.
SAMHSA uses “co-occurring disorders” in its guidance, while noting that terminology in the field varies. SAMHSA’s adoption of the term reflects a broader move in behavioral health toward phrasing that names both conditions directly rather than relying on a vaguer label. This shift also lines up with growing recognition that treating only one condition, while ignoring the other, rarely produces lasting results.
Despite this evolution, “dual diagnosis” never fully disappeared. It remains common in public-facing materials, marketing for treatment programs, and everyday conversation, which is part of why the two terms are often used as if they’re interchangeable today. Clinically, when both terms appear in the same document or conversation, they’re almost always pointing at the same situation: a mental disorder and a substance use disorder present together.
Do diagnostic systems treat these terms differently?
“Dual diagnosis” and “co-occurring disorder” describe combinations of conditions rather than one specific pairing. Clinicians still diagnose each condition separately using standard criteria, such as a specific mood disorder and a specific substance use disorder, and then describe the combination using whichever term their setting prefers.
Clinicians assess and diagnose the individual conditions, while “dual diagnosis” and “co-occurring disorders” describe their coexistence. The terms function more as descriptive shorthand for clinicians and programs than as classification systems in their own right. Distinguishing a substance-induced disorder from an independent mental health disorder still requires careful differential diagnosis, since the formal criteria for conditions like major depressive disorder don’t automatically account for recent substance use.
What changes between settings is emphasis, not diagnostic substance. A primary care clinic might lean on “dual diagnosis” because it’s familiar to patients, while a specialized treatment program might use “co-occurring disorders” to align with the terminology in SAMHSA guidance and insurance documentation. Either way, the underlying diagnostic work, confirming each condition independently and understanding how they interact, stays the same.
Why treating both conditions at once is hard
Treating co-occurring disorders effectively runs into several recurring obstacles. Separating substance-induced symptoms from an independent mental health condition takes time and careful observation, and rushing that process can lead to a missed diagnosis or an unnecessary one. Withdrawal symptoms can complicate the assessment of anxiety, depression, and other mental health symptoms, so clinicians may need to distinguish substance-related symptoms from independent disorders.
Many treatment systems historically kept mental health and addiction services in separate buildings, separate staff teams, and separate funding streams, which made truly integrated care logistically difficult even when everyone agreed it was clinically preferable. Medication management adds another layer of complexity, since some psychiatric medications carry interaction risks with substances or require extra monitoring during early recovery.
Access is a practical barrier too. Programs with the staffing to handle both psychiatric and addiction care, under one roof, with real coordination between the two, are less common than programs that handle one or the other. That gap is part of why asking directly about a program’s integration model matters before admission.
Stigma still shapes how people seek help
Stigma attaches to both halves of a dual diagnosis, sometimes compounding rather than simply adding up. A common misconception is that substance use is a personal failing while mental illness is a medical condition, which can lead people to minimize or hide one issue while seeking help for the other. That framing gets in the way of integrated assessment, since a full picture requires honesty about both.
Another misconception is that someone needs to get “sober first” before mental health treatment can begin, or conversely, that mental health treatment should wait until substance use is fully resolved. Current guidance points the other direction: SAMHSA’s integrated treatment principles call for concurrent treatment precisely because waiting on one condition tends to undermine progress on the other.
Language plays a role here too. Terms used carelessly, like treating “dual diagnosis” as a label for the person rather than a description of two co-occurring conditions, can reinforce the idea that someone is defined by their diagnoses rather than someone living with manageable, treatable conditions. Clearer, person-centered language is part of what pushes back against that.
Evidence-based approaches for treating both conditions together
Several treatment modalities have research support specifically for co-occurring conditions rather than for substance use or mental illness in isolation. Integrated cognitive behavioral therapy, which addresses distorted thinking patterns tied to both the mental health condition and the substance use behavior in the same sessions, is widely used in this space. Medication-assisted treatment, combined with psychiatric medication management, allows clinicians to address substance use and mood or anxiety symptoms at the same time, with monitoring built in for interaction risks.
The comprehensive review on co-occurring treatment points to integrated care models generally, rather than any single therapy, as the approach with the strongest outcomes, emphasizing multi-domain treatment that doesn’t separate the mind from the substance use pattern. Motivational interviewing, trauma-informed care, and contingency management are also commonly layered into integrated programs depending on the specific conditions involved.
Peer support and group therapy formats round out most evidence-based protocols, giving people a space to process both the psychiatric and the substance use sides of their recovery with others who understand the overlap firsthand. Our own integrated treatment approach addresses both psychiatric care and addiction care.
Why a coordinated care team matters
No single clinician is trained to handle every angle of a co-occurring disorder alone. Effective treatment generally requires a team: a psychiatrist or psychiatric nurse practitioner for medication management, addiction counselors trained in substance use treatment, therapists for individual and group work, and case managers handling the practical logistics of recovery. When these roles operate in silos, information gets lost, medication conflicts go unnoticed, and treatment plans end up addressing one condition while neglecting the other.
Coordinated teams also matter for safety. Psychiatric medications and substance use history interact in ways that require real communication between prescribers and addiction specialists, not just a shared chart. Regular team check-ins allow a treatment plan to shift as someone stabilizes, since the balance between psychiatric and addiction-focused care often changes over the course of recovery.
This kind of collaboration is part of why integrated, small-scale residential settings can work well for co-occurring conditions: fewer patients per team allows closer coordination and faster adjustments when something isn’t working. For people exploring remote options, integrated telehealth models are also expanding access to coordinated behavioral health care for people who can’t access in-person programs right away.
Questions worth asking before you commit to a program
The terminology a program uses matters less than what it does with it. Before intake, ask directly how the program defines “dual diagnosis” or “co-occurring disorder,” and ask whether screening covers both substance use and mental health or just one. Ask how psychiatric and addiction services are coordinated day to day, not just at admission.
Expect integrated care to include medication oversight from a psychiatric provider, therapy addressing both conditions, and periodic reassessment as your symptoms shift during recovery, since early withdrawal symptoms often look different from how things settle weeks later. If a program can’t clearly explain how it coordinates care between psychiatric and addiction specialists, that’s worth treating as a signal to look elsewhere or ask for a specialist evaluation before committing.
— Jim
Getting integrated care that treats both conditions as one picture
We built our approach around a simple observation: when programs treat substance use and mental health as separate problems, recovery is slower and relapse risk stays higher. At Sylmar Treatment Center, our six-bed residential setting provides individualized care in a safe and supportive environment.
Our Dual Diagnosis Support program supports people with co-occurring mental health and substance use disorders through individualized treatment. We hold a California DHCS license and Joint Commission accreditation, and offer admissions support for people and families seeking information.
If you’re trying to figure out whether a mental health condition and a substance use pattern are connected, or you already know they are and need a program built to treat both at once, reach out to our admissions team to talk through what integrated care would look like for your specific situation.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Is codependency a diagnosis in the DSM-5?
No, codependency is not a recognized diagnosis in the DSM-5. It is a descriptive term used in some clinical and support settings to describe relationship patterns, but it lacks formal diagnostic criteria like those for substance use disorders or mood disorders.
What is an example of dual diagnosis?
A common example is major depressive disorder occurring alongside alcohol use disorder, where a person experiences persistent low mood while also meeting criteria for problematic alcohol use. Other frequent examples include PTSD with opioid use disorder and ADHD with stimulant misuse, since these pairings show up often in SAMHSA’s co-occurring disorders guidance.
What are some examples of serious mental health disorders?
Serious mental health disorders commonly discussed alongside substance use include major depressive disorder, bipolar disorder, PTSD, schizophrenia, and generalized anxiety disorder. These conditions can occur with or without a co-occurring substance use disorder, though the combination often requires integrated treatment.
Is addiction a mental illness?
Substance use disorder is classified as a mental health condition in diagnostic systems, with its own set of clinical criteria separate from other psychiatric diagnoses. That classification is part of why integrated treatment, addressing substance use and other mental health conditions together, is the approach recommended in SAMHSA’s treatment guidance.
Sources
- Dual Diagnosis: MedlinePlus
- Co-Occurring Disorders and Other Health Conditions | SAMHSA
- Pubmed
- Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review